Zemplar and septic shock 
Zemplar and septic shock Patient Reports February 10, 2012
Zemplar Side Effects Report #5505622-2
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Oct 29, 2007. Male patient, 71 years of age, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: infected skin ulcer, septic shock. Zemplar dosage: unknown. Patient died on 10/20/2007.
Zemplar Side Effects Report #5575215-X
Zemplar side effect was reported by a Physician from GREECE on Dec 17, 2007. Male patient, 71 years of age, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: infected skin ulcer, septic shock. Zemplar dosage: unknown. During the same period patient was treated with EVATON AMP, INTELECTA AMP, FOLIC ACID, ATORVASTATIN CALCIUM, CLOPIDOGREL BISULPHATE, ISOSORBIDE MONONITRATE, PENTOXIFYLLINE, EPOETIN BETA. Patient died on 10/20/2007.
Zemplar Side Effects Report #6046720-7
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Jan 20, 2009. Female patient, 68 years of age, weighting 132.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: necrotising fasciitis, septic shock. Zemplar dosage: unknown. During the same period patient was treated with NEORECORMON, FERROVINE, SUPERAMIN, NEUROBION, RENAGEL, NEURONTIN, ISCOVER, THYRORMONE. Patient was hospitalized. Patient died on 01/08/2009.
Zemplar Side Effects Report #6097993-6
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Feb 17, 2009. Female patient, 68 years of age, weighting 132.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: immunosuppression, necrotising fasciitis, septic shock, unevaluable event. Zemplar dosage: unknown. During the same period patient was treated with NEORECORMON, FERROVINE, SUPERAMIN, NEUROBION, RENAGEL, NEURONTIN, ISCOVER, THYRORMONE. Patient was hospitalized. Patient died on 01/08/2009.
Zemplar Side Effects Report #5202892-5
Zemplar side effect was reported by a Physician from VENEZUELA on Jan 08, 2007. Female patient, weighting 108.0 lb, was diagnosed with hyperparathyroidism secondary, anaemia, vitamin supplementation, hypophosphataemia, diabetes mellitus, hypertension and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cholecystitis, septic shock. Zemplar dosage: unknown. During the same period patient was treated with ERITROPOIETIN, FOLIC ACID, CALCIUM CARBONATE, ISOPHANE INSULIN, INSULIN CRYST, LOSARTAN POTASSIUM. Patient died on 11/04/2006.
Zemplar Side Effects Report #5273082-5
Zemplar side effect was reported by a Physician from VENEZUELA on Mar 14, 2007. Male patient, weighting 147.7 lb, was diagnosed with hyperparathyroidism secondary, cardiac failure, hypertension, vitamin supplementation, anaemia, blood phosphorus increased, gastrooesophageal reflux disease and was treated with Zemplar. After drug was administered, patient experienced the following side effects: discomfort, dyspnoea, lower respiratory tract infection, respiratory disorder, retinal operation, septic shock. Zemplar dosage: unknown. During the same period patient was treated with CARVEDILOL, AMLODIPINE, BENUTREX, FOLIC ACID, EPOGEN, CALCIUM CARBONATE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #5289776-1
Zemplar side effect was reported by a Physician from VENEZUELA on Mar 29, 2007. Male patient, weighting 147.7 lb, was diagnosed with hyperparathyroidism secondary, cardiac failure, hypertension, vitamin supplementation, anaemia, blood phosphorus increased, gastrooesophageal reflux disease and was treated with Zemplar. After drug was administered, patient experienced the following side effects: discomfort, dyspnoea, lower respiratory tract infection, respiratory disorder, retinal operation, septic shock. Zemplar dosage: unknown. During the same period patient was treated with CARVEDILOL, AMLODIPINE, BENUTREX, FOLIC ACID, EPOGEN, CALCIUM CARBONATE, OMEPRAZOLE. Patient was hospitalized. Patient died on 03/27/2007.
Zemplar Side Effects Report #5152724-9
Zemplar side effect was reported by a Physician from VENEZUELA on Nov 06, 2006. Female patient, weighting 108.0 lb, was diagnosed with hyperparathyroidism secondary, anaemia, vitamin supplementation, hypophosphataemia, diabetes mellitus, hypertension and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cholecystitis, septic shock. Zemplar dosage: unknown. During the same period patient was treated with ERITROPOIETIN, FOLIC ACID, CALCIUM CARBONATE, ISOPHANE INSULIN, INSULIN CRYST, LOSARTAN POSTASSIUM. Patient died on 11/04/2006.
Zemplar Side Effects Report #5154215-8
Zemplar side effect was reported by a Physician from VENEZUELA on Nov 06, 2006. Female patient, weighting 108.0 lb, was diagnosed with hyperparathyroidism secondary, anaemia, vitamin supplementation, hypophosphataemia, diabetes mellitus, hypertension and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cholecystitis, septic shock. Zemplar dosage: unknown. During the same period patient was treated with ERITROPOIETIN, FOLIC ACID, CALCIUM CARBONATE, ISOPHANE INSULIN, INSULIN CRYST, LOSARTAN POSTASSIUM. Patient died on 11/04/2006.
Zemplar Side Effects Report #5162314-X
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Nov 20, 2006. Female patient, weighting 244.7 lb, was diagnosed with hyperparathyroidism secondary, renal failure chronic, hypertension, haemodialysis, hyperlipidaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiopulmonary failure, chills, influenza, nasopharyngitis, septic shock, tachycardia, vomiting. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDTE, METOPROLOL TARTRATE, SEVELAMER HYDROCHLORIDE, FENOFIBRATE, ACETYLSALICYLIC ACID SRT, CINARIZIN, PENTOXIFYLLINE. Patient was hospitalized. Patient died on 10/18/2006.
Zemplar Side Effects Report #5163059-2
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Nov 20, 2006. Female patient, weighting 244.7 lb, was diagnosed with hyperparathyroidism secondary, renal failure chronic, hypertension, haemodialysis, hyperlipidaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiopulmonary failure, chills, influenza, nasopharyngitis, septic shock, tachycardia, vomiting. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDTE, METOPROLOL TARTRATE, SEVELAMER HYDROCHLORIDE, FENOFIBRATE, ACETYLSALICYLIC ACID SRT, CINARIZIN, PENTOXIFYLLINE. Patient was hospitalized. Patient died on 10/18/2006.
Zemplar Side Effects Report #5167361-X
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Nov 20, 2006. Female patient, weighting 244.7 lb, was diagnosed with hyperparathyroidism secondary, renal failure chronic, hypertension, haemodialysis, hyperlipidaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiopulmonary failure, chills, influenza, nasopharyngitis, septic shock, tachycardia, vomiting. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDTE, METOPROLOL TARTRATE, SEVELAMER HYDROCHLORIDE, FENOFIBRATE, ACETYLSALICYLIC ACID SRT, CINARIZIN, PENTOXIFYLLINE. Patient was hospitalized. Patient died on 10/18/2006.
Zemplar Side Effects Report #5475369-X
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Sept 27, 2007. Male patient, weighting 133.4 lb, was diagnosed with hyperparathyroidism secondary, anaemia, hypertension, uraemic pruritus, coronary artery disease
, vitamin supplementation, hyperphosphataemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: septic shock. Zemplar dosage: unknown. During the same period patient was treated with DARBEPOETIN ALFA, AMLOPEN, CETIRIZINE, CARVEDILOL, FOLIC ACID, SEVELAMER. Patient was hospitalized. Patient died on 09/26/2007.Zemplar Side Effects Report #5505853-1
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Oct 24, 2007. Male patient, weighting 133.4 lb, was diagnosed with hyperparathyroidism secondary, anaemia, hypertension, uraemic pruritus, coronary artery disease
, vitamin supplementation, hyperphosphataemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: septic shock. Zemplar dosage: unknown. During the same period patient was treated with DARBEPOETIN ALFA, AMLOPEN, CETIRIZINE HYDROCHLORIDE, CARVEDILOL, FOLIC ACID, SEVELAMER. Patient was hospitalized. Patient died on 09/26/2007.Zemplar Side Effects Report #5854700-7
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Aug 20, 2008. Male patient, weighting 187.4 lb, was diagnosed with hyperparathyroidism secondary, anaemia, blood phosphorus increased and was treated with Zemplar. After drug was administered, patient experienced the following side effects: fluid retention, hyperkalaemia, pyrexia, respiratory tract infection, septic shock. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN ALFA, FOLIC ACID, ACETYLSALICYLIC ACID SRT, PERSAMAR, ALUCAP CAPS, TICLOPIDINE HYDROCHLORIDE, CINACALCET. Patient was hospitalized. Patient died on 08/17/2008.
Zemplar Side Effects Report #5878324-0
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Sept 09, 2008. Male patient, weighting 187.4 lb, was diagnosed with hyperparathyroidism secondary, anaemia, blood phosphorus increased and was treated with Zemplar. After drug was administered, patient experienced the following side effects: fluid retention, hyperkalaemia, pyrexia, respiratory tract infection, septic shock. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN ALFA, FOLIC ACID, ACETYLSALICYLIC ACID SRT, PERSAMAR, ALUCAP CAPS, TICLOPIDINE HYDROCHLORIDE, CINACALCET. Patient was hospitalized. Patient died on 08/17/2008.
Zemplar Side Effects Report #6029008-X
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Dec 29, 2008. Male patient, weighting 187.4 lb, was diagnosed with hyperparathyroidism secondary, anaemia, blood phosphorus increased and was treated with Zemplar. After drug was administered, patient experienced the following side effects: fluid retention, hyperkalaemia, pyrexia, respiratory tract infection, septic shock. Zemplar dosage: unknown. During the same period patient was treated with EPREX, FILICINE, SALOSPIR, PERSAMAR, ALUCAP CAPS, TICLID, MIMPARA. Patient was hospitalized. Patient died on 08/17/2008.
Zemplar Side Effects Report #4985109-6
Zemplar side effect was reported by a Physician from SPAIN on Apr 11, 2006. Male patient, weighting 115.7 lb, was diagnosed with hyperparathyroidism secondary, hypertension and was treated with Zemplar. After drug was administered, patient experienced the following side effects: blood parathyroid hormone decreased, pneumonia
, septic shock. Zemplar dosage: unknown. During the same period patient was treated with FOLIC ACID, ENALAPRIL MALEATE, AMLODIPINE, OMEPRAZOL. Patient was hospitalized. Patient died on 04/11/2006.